Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
24,004,205
-
Share change
-
+162,696
-
Total reported value
-
$389,593,530
-
Price per share
-
$16.23
-
Number of holders
-
83
-
Value change
-
+$5,713,245
-
Number of buys
-
50
-
Number of sells
-
31
Institutional Holders of OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) as of Q3 2018
As of 30 Sep 2018,
OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,004,205 shares.
The largest 10 holders included
Invesco Ltd., Polar Capital LLP, Consonance Capital Management LP, Redmile Group, LLC, Alyeska Investment Group, L.P., First Light Asset Management, LLC, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GRANAHAN INVESTMENT MANAGEMENT INC/MA, and WASATCH ADVISORS INC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.